Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT06054776 · RECRUITING
Trial details
- NCT number
- NCT06054776
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-02
- Primary completion
- 2026-10-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.